153 related articles for article (PubMed ID: 34602470)
1. Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment.
Russin KJ; Nair KS; Montine TJ; Baker LD; Craft S
J Alzheimers Dis; 2021; 84(2):843-853. PubMed ID: 34602470
[TBL] [Abstract][Full Text] [Related]
2. Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial.
Hoscheidt S; Sanderlin AH; Baker LD; Jung Y; Lockhart S; Kellar D; Whitlow CT; Hanson AJ; Friedman S; Register T; Leverenz JB; Craft S
Alzheimers Dement; 2022 Mar; 18(3):457-468. PubMed ID: 34310044
[TBL] [Abstract][Full Text] [Related]
3. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.
Bayer-Carter JL; Green PS; Montine TJ; VanFossen B; Baker LD; Watson GS; Bonner LM; Callaghan M; Leverenz JB; Walter BK; Tsai E; Plymate SR; Postupna N; Wilkinson CW; Zhang J; Lampe J; Kahn SE; Craft S
Arch Neurol; 2011 Jun; 68(6):743-52. PubMed ID: 21670398
[TBL] [Abstract][Full Text] [Related]
4. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
5. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment.
Baker LD; Bayer-Carter JL; Skinner J; Montine TJ; Cholerton BA; Callaghan M; Leverenz JB; Walter BK; Tsai E; Postupna N; Lampe J; Craft S
J Alzheimers Dis; 2012; 28(1):137-46. PubMed ID: 21971406
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
[TBL] [Abstract][Full Text] [Related]
7. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
8. Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Kresge HA; Liu D; Gupta DK; Moore EE; Osborn KE; Acosta LMY; Bell SP; Pechman KR; Gifford KA; Mendes LA; Wang TJ; Blennow K; Zetterberg H; Hohman TJ; Jefferson AL
J Alzheimers Dis; 2020; 74(3):965-974. PubMed ID: 32144980
[TBL] [Abstract][Full Text] [Related]
9. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
10. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.
Tautvydaitė D; Kukreja D; Antonietti JP; Henry H; von Gunten A; Popp J
Alzheimers Res Ther; 2017 Feb; 9(1):6. PubMed ID: 28153054
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum.
Lee J; Jang H; Kang SH; Kim J; Kim JS; Kim JP; Kim HJ; Seo SW; Na DL
J Korean Med Sci; 2020 Nov; 35(44):e361. PubMed ID: 33200589
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
[TBL] [Abstract][Full Text] [Related]
13. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
[TBL] [Abstract][Full Text] [Related]
14. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
[TBL] [Abstract][Full Text] [Related]
15. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting.
Lanari A; Parnetti L
ScientificWorldJournal; 2009 Sep; 9():961-6. PubMed ID: 19768352
[TBL] [Abstract][Full Text] [Related]
17. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
[TBL] [Abstract][Full Text] [Related]
19. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.
Hanson AJ; Bayer-Carter JL; Green PS; Montine TJ; Wilkinson CW; Baker LD; Watson GS; Bonner LM; Callaghan M; Leverenz JB; Tsai E; Postupna N; Zhang J; Lampe J; Craft S
JAMA Neurol; 2013 Aug; 70(8):972-80. PubMed ID: 23779114
[TBL] [Abstract][Full Text] [Related]
20. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
